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Quercetin ameliorates inflammation in CA1 hippocampal region in 
aged triple transgenic Alzheimer´s disease mice model.
Felipe Vargas-Restrepo, Angélica María Sabogal-Guáqueta, Gloria Patricia Cardona-Gómez
Área de Neurobiología Celular y Molecular, Grupo de Neurociencias de Antioquia, 
Facultad de Medicina, Universidad de Antioquia, Medellín, Colombia
Introduction: Alzheimer’s disease is the most common form of dementia. It is characterized by 
histopathological hallmarks such as senile plaques and neurofibrillary tangles, as well as a concomitant 
activation of microglial cells and astrocytes that release pro-inflammatory mediators such as IL-1β, 
iNOS, and COX-2, leading to neuronal dysfunction and death.
Objective: To evaluate the effect of quercetin on the inflammatory response in the CA1 area of the 
hippocampus in a 3xTg-AD male and female mice model.
Materials and methods: Animals were injected intraperitoneally with quercetin every 48 hours during 
three months, and we conducted histological and biochemical studies.
Results: We found that in quercetin-treated 3xTg-AD mice, reactive microglia and fluorescence 
intensity of Aβ aggregates significantly decreased. GFAP, iNOS, and COX-2 immunoreactivity also 
decreased and we observed a clear tendency in the reduction of IL-1β in hippocampal lysates.
Conclusion: Our work suggests an anti-inflammatory effect of quercetin in the CA1 hippocampal 
region of aged triple transgenic Alzheimer’s disease mice.
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La quercetina disminuye la inflamación en la región CA1 del hipocampo en un modelo de ratón 
triple transgénico para la enfermedad de Alzheimer.
Introducción. La enfermedad de Alzheimer es la forma más común de demencia; se caracteriza por 
la presencia de marcadores histopatológicos, como las placas seniles y los ovillos neurofibrilares, así 
como por una activación concomitante de células microgliales y astrocitos que liberan mediadores 
proinflamatorios, como IL-1β, iNOS y COX-2, lo cual conduce a la disfunción y la muerte neuronal.
Objetivo. Evaluar el efecto de la quercetina sobre la reacción inflamatoria en el área CA1 del hipocampo 
en un modelo de ratones 3xTg-AD.
Materiales y métodos. Los animales se inyectaron intraperitonealmente con quercetina cada 48 horas 
durante tres meses, y se hicieron estudios histológicos y bioquímicos. 
Resultados. Se encontró que en los animales 3xTg-AD tratados con quercetina, la microglía reactiva 
y la intensidad de fluorescencia de los agregados Aβ disminuyeron significativamente, y que hubo una 
menor reacción de GFAP, iNOS y COX-2, así como una clara tendencia a la reducción de la IL-1 β en 
lisados de hipocampo.
Conclusión. Los resultados del estudio sugieren un efecto antiinflamatorio de la quercetina en la 
región CA1 del hipocampo en un modelo en ratón triple trasgénico para la enfermedad de Alzheimer. 
Palabras clave: enfermedad de Alzheimer; quercetina; microglía; astrocitos.
doi: https://doi.org/10.7705/biomedica.v38i0.3761
Alzheimer´s disease is the most common form of 
dementia, which is characterized by a progressive 
loss of memory and other cognitive functions. Its 
main histopathological hallmarks are extracellular 
beta-amyloid (βA) accumulation in senile plaques 
and intracellular hyperphosphorylated tau protein 
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forming neurofibrillary tangles (1). These aggre-
gates induce an inflammatory response by the 
microglia and astrocytes that allow a gradual activa-
tion and subsequent production of pro-inflammatory 
mediators leading to neurodegeneration (2).
Microglial cells and astrocytes are involved in 
the inflammatory response in the central nervous 
system (CNS). Microglia remain in a resting state 
exhibiting a branched morphology; once they 
are activated by the presence of βA the size of 
the soma in the cell increases and the number of 
processes decreases acquiring an amoeboid form 
with absence or presence of shorter branches (3). 
Their ability to engulf βA peptides reduces while 
the production of pro-inflammatory mediators 
increases (3,4). Astrocytes also have a ramified 
morphology when they are in resting state, but 
after the onset of the Alzheimer’s disease, they 
acquire a hypertrophic morphology with a reduction 
of branches and processes, and an increased cell 
soma (5). As is the case for microglia, astrocytes 
increase the production of pro-inflammatory media-
tors when they are activated (6).
Among the most important inflammatory media-
tors produced by microglial cells and astrocytes in 
Alzheimer’s disease are the interleukin 1β (IL-1β), 
the inducible nitric oxide synthase (iNOS) and the 
cyclooxygenase 2 (COX-2). IL-1β is produced 
by those cells surrounding βA plaques (7), and it 
can modulate tau hyperphosphorylation through 
activated microglia and p38-MAPK activation 
(7,8). The other inflammatory mediator involved 
in neuroinflammation in the disease is iNOS. This 
enzyme is expressed in response to immunological 
challenges or by damaged tissue producing nitric 
oxide (NO) (9), which causes DNA damage and 
induces the production of peroxynitrites that destroy 
the mitochondria and reduce ATP formation (10). 
High levels of βA increase iNOS expression and NO 
production in microglia and astrocytes (9,11). COX-
2 is an inducible enzyme in pathological conditions 
and it catalyzes the synthesis of prostaglandins, 
many of which are neurotoxic, such as prostaglandin 
E2 (PGE2), which is the main produced inflammatory 
prostaglandin (12). βA peptides induce the activa-
tion of PGE2 in astrocytes and microglia (6,12), 
which can produce an increase in astrocyte prolifera-
tion in vivo and diminish the ability of microglia to 
phagocytose βA peptides (13,14).
Quercetin is a molecule with neuroprotective pro-
perties which may increase the neuronal resist-
ance against oxidative stress by βA (15,16). In 
our previous studies, we have demonstrated that 
quercetin reduces histopathological hallmarks 
improving cognitive and emotional skills in a 3xTg-
AD mice model (17). Given that  the hippocampus 
CA1 region is a vulnerable area for excitotoxicity 
and neuronal death in Alzheimer’s disease (18), in 
this study we evaluated the effect of quercetin on 
the pro-inflammatory response.
Materials and methods
Animals
Male and female homozygous 3xTg-AD for 
APP (Swe), tau (P301L), PS1 (M146V), and 
knocking-PS1 mice (Non-3xTg) (M146V) (19) 
from our in-house colony were maintained at the 
specific pathogen-free vivarium of the Sede de 
Investigación Universitaria at the Universidad de 
Antioquia in Medellín. We assigned animals of 
18 to 21 months of age randomly to the vehicles 
(DMSO) or quercetin groups regardless of their 
transgenic or non-transgenic condition (non-Tg). 
3xTg-AD mice had a homogenous β-amyloidosis 
and tauopathy penetrance. 
The animals were handled according to Colom-
bian standards and guidelines (Law 84/1989 and 
Resolution 8430/1993); the protocol was approved 
by the Ethics Committee of the Universidad de 
Antioquia for animal experimentation. Special care 
was taken to minimize animal suffering and to 
reduce the number of animals used.
Administration of drugs
The 3xTg-AD and non-Tg mice received 25 mg/
kg intraperitoneal injections of quercetin or 0.1% 
DMSO every 48 hours for three consecutive months, 
as previously described (17).
Histology and immunohistochemistry
Animals were intracardially perfused using 4% 
paraformaldehyde, and 50 µm coronal sections 
were used for Nissl (toluidine blue) staining and 
immunohistochemistry evaluation as previously 
described (17). We assessed the CA1 region at 
bregma -1.82 and -2.06 mm. Anti-GFAP (1:1000, 
Sigma # G3893), anti-iNOS (1:250, C-11, Santa 
Cruz Biotechnology, Sc # 7271) (permeabilizing 
tissues 10 mM Tris pH 6, overnight at 4°C) were 
the mouse primary antibodies used together with 
the Iba1 anti-rabbit primary antibody (1:500, Wako 
# 019-19741) as microglia and COX-2 markers 
(1:500, # AB15191, Abcam). 
To determine immunoreactivity (IR) densitometry 
we used a 10X objective and we analyzed it with 
the Fiji ImageJ 1.45 software (NIH, USA) based on 
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staining intensity. The number of animals per group 
was three in non-Tg quercetin animals and four in 
the other groups. 
Immunofluorescence
We rinsed 50 µm coronal sections at bregma -1.82 
and -2.06 mm in 0.1 M PBS following a previously 
published protocol (20). Sections were incubated 
with β-amyloid anti-mouse primary antibody (1:500, 
β amyloid 1-16 (6E10) # SIG-39320, Covance), 
and Iba1 anti-rabbit primary antibody (1:500, # 
019-19741, Wako). We analyzed the sections by 
using a motorized spinning disk confocal micro-
scope (Olympus IX81-DSU). The omission of the 
primary antibodies resulted in no staining. Camera 
exposure time and gain were adjusted so that no 
pixel saturation was present in any channel, and 
identical camera settings were used for all images 
in each experiment.
Immunofluorescence (IF) was determined using 
a 10X objective and analyzed by Fiji ImageJ 1.45 
software (NIH, USA) based on staining intensity. 
We processed all experimental groups at the 
same time for minimizing variability. The number of 
animals per group was three for non-Tg quercetin 
animals and four for the other groups.
ELISA IL-1b
We measured IL-1β using the Quantikine ELISA 
Mouse IL-1β kit™ (Cat. # MLB00C, RyD Systems, 
Minneapolis, USA) following the manufacturer’s 
protocol with a peptide concentration of 50 µg/
ml. The number of animals per group was two for 
3xTg-DMSO animals and four for the other groups.
Western blotting
The procedure was performed as described pre-
viously (17). Briefly, anti-NOS2, anti-COX2, and 
anti-Tubulin (1:10000, monoclonal anti-βIII tubulin, 
# G712A, Promega, AB_430874) were used as 
loading control, and CW IRDye 680 goat anti-
mouse or rabbit 800 (LI-COR, diluted 1: 10000) 
were used as secondary antibodies. Fluorescence 
intensity was analyzed using the Odyssey Infrared 
Imaging System™ application software, version 
3.0 (LI-COR, ODY-1735). We used four animals in 
each group.
Statistical analysis
We randomly processed the data collected. We 
used at least three mice in each group for histo-
logical evaluation and four in each group for bio-
chemical analyses. We evaluated data with a normal 
distribution using analysis of variance (ANOVA) to 
compare the four experimental groups, and then 
Tukey’s test as post-hoc multiple comparison when 
appropriate. When the conditions of normality 
of the data distribution and variances were not 
normal we used the nonparametric Kruskal-Wallis 
test. The statistical analysis was performed using 
GraphPad Prism software (version 6.0), and results 
were considered to be significant at p≤0.05. The 
values were expressed as the mean ± SEM.
Results
Quercetin reduces β-amyloid aggregation and 
microglial immunoreactivity in aged 3xTgAD 
mice.
We confirmed an increased fluorescence intensity 
(FI) of the microglial population and βA plaques in 
3xTg-AD mice compared to non-Tg animals (figure 
1A). Interestingly, quercetin treatment reduced sig- 
nificantly the Iba-1 (34%) and βA (48%) FI in the 
CA1 region of aged 3xTg-AD mice compared to 
untreated 3xTg-AD mice (figure 1B,C). Microglia 
showed increased cell body size similar to amoe-
boid shape in untreated 3xTgAD mice, which was 
blocked by the quercetin treatment in aged animals 
(figure 1A).
Quercetin ameliorates astrogliosis in aged 
3xTgAD mice.
We qualitatively assessed pyramidal layer of the 
CA1 area in relation to the cell cytoarchitecture 
and the presence of microglial cells using a Nissl-
Iba1 IR counterstaining. We detected an increased 
cellular condensation and irregular morphology 
in aged 3xTgAD mice surrounded by Iba1+ cells 
(figure 2A). These observations were supported 
by hypertrophied astrocytes, which showed a 
significant increase in the GFAP immunoreactivity 
(33%), compared with untreated and treated control 
groups (figure 2B). However, with the quercetin 
treatment mice recovered a similar morphological 
shape and reactivity in the CA1 area to those of 
control groups (figure 2 A, B).
Inflammatory mediators are down-regulated 
by quercetin in the CA1 area of 3xTgAD mice 
hippocampus.
The hippocampus CA1 area of 3xTgAD mice showed 
a significant increase of iNOS immunoreactivity 
with a diffuse distribution in the parenchyma (figure 
3A, B). COX-2 reactivity also showed a vessel-like 
elongated pattern, which significantly increased 
in the Alzheimer’s disease model (figure 3A, C). 
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Quercetin-treated mice presented a significant 
reduction in immunostaining in the CA1 area 
(figure 3A,B,C), supported by normal IL-1β levels 
in comparison to the untreated 3xTg-AD group and 
similar to the control groups (figure 3 D). However, 
hippocampal total lysates did not show significant 
changes in the iNOS and COX-2 protein levels 
(figure 3 E).
Discussion
Findings suggested a reduction of the pro-
inflammatory response in the CA1 hippocampal 
region of aged 3xTg-AD mice with the use of 
quercetin, confirming our recent results where 
quercetin reversed β-amyloidosis and tauopathy 
associated to cognitive and emotional behavioral 
improvement (17).
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Figure 1. Quercetin reduced the Iba-1 and βA fluorescence intensities in CA1 area of aged 3xTg-AD mice. (A) Immunofluorescence 
microglial (green) and Aβ plaques (red) from CA1 region. 10X and 60X; scale bar: 50µm and 5µm, respectively. (B) Fluorescence 
intensity quantification of Iba-1 positive cells. 10X. (C) Fluorescence intensity quantification in aggregates Aβ 10X. Data presented 
as mean ± SEM. n: 3-4, * (p<0.05) ** (p=0.001), *** (p<0.001)
Figure 2. Quercetin recovered altered cell cytoarchitecture and ameliorated astrogliosis in the CA1 area from aged 3xTgAD mice. 
A) Representative images of Nissl-Iba-1 counterstaining. B) GFAP immunohistochemistry for astrocytes, and quantification of GFAP 
immunoreactivity shown as densitometric relative units (RU) in CA1. 10X and 40X; scale bar: 50 µm and 15 µm, respectively. Data 
expressed as the mean ± SEM. n: 3-4. **p<0.01
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In a pathological context, βA aggregates can acti-
vate microglia cells and astrocytes generating 
local inflammation and amplifying neuronal death 
signaling (21). In our study, the CA1 hippocampal 
area of aged 3xTgAD mice presented a pro-
inflammatory environment marked by β-amyloid 
plaques surrounded by microgliosis associated to 
hypertrophied astrocytes and condensed pyram-
idal layer. These changes were accompanied by 
the up-regulation of IL-1β, COX-2, and iNOS, which 
could be specific for the CA1 area, as they were not 
detected in the total hippocampal lysates.
Human Alzheimer’s disease and models are charac-
terized by a high microglial hyperreactivity (1,3), 
which increases the release of proinflammatory 
cytokines and decreases βA clearance (4,22). For 
this reason, IL-1β stimulates the production of COX-
2 by microglial cells in brains affected by Alzheimer’s 
disease (23), which favors the expression of iNOS 
through PGE2 production (24), although IL-1β also 
directly activates before iNOS (7). In a positive 
feedback, PGE2 also induces microgliosis and this 
promotes astrocyte proliferation (13). Recently, it 
was found that microglial-specific deletion of PGE2 
restores microglial chemotaxis and βA clearance 
suppresses toxicity of the exacerbated pro-inflam-
matory response and microglial activation (25,26). 
On the other hand, astrocytes reactivated by their 
interaction with βA release IL-1β, iNOS, and COX-
2 amplifying the immune response (5,6,12). This 
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Figure 3. Proinflammatory indicators were reduced by quercetin treatment in the CA1 area of 3xTgAD mice hippocampus. A) iNOS 
and COX-2 immunohistochemistry in CA1 region.10X and 40X; scale bar: 50 µm and 15 µm, respectively. B) iNOS, and C) COX-
2 immunoreactivity quantification at 10X. D) IL-1β hippocampal lysate quantification in non-Tg and Tg mice with DMSO and QC 
treatment. E) Representative bands of iNOS and COX-2 in hippocampal lysates and densitometric quantification of iNOS and COX-
2. Tubulin was used as control load. Immunohistochemistry (n: 3-5) and ELISA (n: 2-4). Data presented as mean ± SEM. * (p<0.05) 
** (p=0.001), *** (p<0.001). For Western blotting, data are presented as mean ± SEM. n=4, (p<0.005)
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exacerbated reactivity causes astrocyte atrophy, 
which may also result in a reduced proteolytic 
clearance of βA and contribute to the extracellular 
βA accumulation and the decrease of neuronal 
support (27-29). 
Our findings suggest that the quercetin treatment 
induced an anti-inflammatory response confirming 
previous studies where the compound decreases 
the production of inflammatory mediators such as 
iNOS, NO, COX-2, PGE2, and IL-1β and reduces 
the activation of microglia and astrocytes (30-33). 
Furthermore, quercetin contributes to the reduction 
of oxidative stress, since it increases the production 
of antioxidant enzymes in astrocytes, microglia 
and neurons (34,35). Thus, quercetin might help 
to inhibit the feedback among proinflammatory 
mediators and glial cells avoiding the spreading of 
neuronal damage. 
Interestingly, our results showed that the quercetin 
treatment also reverses the immune response in 
an advanced stage of the disease in the model 
under study. This suggests that the induction of 
βA phagocytosis (4,36) and the decrease in the 
release of neurotoxic cytokines (2) are mediating 
the protective action of quercetin, because in our 
previous observations quercetin did not regulate 
typical tauopathy mediator enzymes, such as 
CDK5 and GSK3-beta (17). However, quercetin 
might reduce tauopathy by the regulation of IL-1 
β/p38 MAPK activation (8) and, thus, improve 
cognitive performance (17). Other protective effects 
have been described for quercetin in restoring the 
expression of genes perturbed by βA accumula-
tion including DNA replication, cell cycle proteins, 
hypoxia response, de novo pyrimidine deoxyri-
bonucleotide biosynthesis, p53 pathway and βA 
metabolism regulation and in decreasing βA40 and 
βA42 species by the stabilization of astrocytes-
derived apolipoprotein E (37,38). 
Our work suggests an anti-inflammatory effect of 
quercetin in hippocampal CA1 region in a model for 
Alzheimer’s disease of triple transgenic aged mice 
by reducing β-amyloid plaques aggregation and 
microglial and astroglial reactivity as reflected in the 
decrease of IL-1β/ COX-2/ iNOS pro-inflammatory 
signaling, which could be closely related to previous 
findings on the reversal of tauopathy, as well as 
emotional and cognitive impairment. 
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